Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2025-12-25 @ 8:08 PM
Study NCT ID:
NCT06176261
Status:
RECRUITING
Last Update Posted:
2025-07-30
First Post:
2023-12-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Sponsor:
Sarah Sammons, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-08
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-07
First Submit QC Date:
None
Study First Post Date:
2023-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-28
Last Update Post Date:
2025-07-30
Last Update Post Date Type:
ACTUAL